CDKN2A and non-small cell lung carcinoma: Deregulated expression of p16INK4A occurs in 43% of NSCLCs but is not related to the clinical stage of the tumors, but smoking was associated with aberrant expression of p16INK4A/pRB, suggesting that abnormalities in this network occur early in the development of NSCLC subset [74].